606 related articles for article (PubMed ID: 14678947)
1. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
McWhinney CD; Dostal D; Baker K
J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose.
Amiri F; Shaw S; Wang X; Tang J; Waller JL; Eaton DC; Marrero MB
Kidney Int; 2002 May; 61(5):1605-16. PubMed ID: 11967010
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation.
Banes-Berceli AK; Ketsawatsomkron P; Ogbi S; Patel B; Pollock DM; Marrero MB
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1291-9. PubMed ID: 17526654
[TBL] [Abstract][Full Text] [Related]
5. Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells.
Hernández-Vargas P; López-Franco O; Sanjuán G; Rupérez M; Ortiz-Muñoz G; Suzuki Y; Aguado-Roncero P; Pérez-Tejerizo G; Blanco J; Egido J; Ruiz-Ortega M; Gómez-Guerrero C
J Am Soc Nephrol; 2005 Jun; 16(6):1673-83. PubMed ID: 15829701
[TBL] [Abstract][Full Text] [Related]
6. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
[TBL] [Abstract][Full Text] [Related]
7. Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats.
Omura T; Yoshiyama M; Ishikura F; Kobayashi H; Takeuchi K; Beppu S; Yoshikawa J
J Mol Cell Cardiol; 2001 Feb; 33(2):307-16. PubMed ID: 11162135
[TBL] [Abstract][Full Text] [Related]
8. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells.
Gallmeier E; Schäfer C; Moubarak P; Tietz A; Plössl I; Huss R; Göke B; Wagner AC
J Cell Physiol; 2005 Apr; 203(1):209-16. PubMed ID: 15493010
[TBL] [Abstract][Full Text] [Related]
9. The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes.
McWhinney CD; Hunt RA; Conrad KM; Dostal DE; Baker KM
J Mol Cell Cardiol; 1997 Sep; 29(9):2513-24. PubMed ID: 9299374
[TBL] [Abstract][Full Text] [Related]
10. The functional role of the JAK-STAT pathway in post-infarction remodeling.
El-Adawi H; Deng L; Tramontano A; Smith S; Mascareno E; Ganguly K; Castillo R; El-Sherif N
Cardiovasc Res; 2003 Jan; 57(1):129-38. PubMed ID: 12504822
[TBL] [Abstract][Full Text] [Related]
11. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
12. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
13. Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats.
Li PG; Xu JW; Ikeda K; Kobayakawa A; Kayano Y; Mitani T; Ikami T; Yamori Y
Hypertens Res; 2005 Apr; 28(4):369-77. PubMed ID: 16138568
[TBL] [Abstract][Full Text] [Related]
14. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.
Marrero MB; Venema VJ; Ju H; Eaton DC; Venema RC
Am J Physiol; 1998 Nov; 275(5):C1216-23. PubMed ID: 9814969
[TBL] [Abstract][Full Text] [Related]
15. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cardiac Jak-2 in animal models of insulin resistance.
Rojas FA; Carvalho CR; Paez-Espinosa V; Saad MJ
IUBMB Life; 2000 Jun; 49(6):501-9. PubMed ID: 11032244
[TBL] [Abstract][Full Text] [Related]
17. Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells.
Liang H; Venema VJ; Wang X; Ju H; Venema RC; Marrero MB
J Biol Chem; 1999 Jul; 274(28):19846-51. PubMed ID: 10391929
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the Jak/STAT signaling pathway prevents the high glucose-induced increase in tgf-beta and fibronectin synthesis in mesangial cells.
Wang X; Shaw S; Amiri F; Eaton DC; Marrero MB
Diabetes; 2002 Dec; 51(12):3505-9. PubMed ID: 12453907
[TBL] [Abstract][Full Text] [Related]
19. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
Yu WM; Hawley TS; Hawley RG; Qu CK
Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
[TBL] [Abstract][Full Text] [Related]
20. Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia.
Natarajan C; Sriram S; Muthian G; Bright JJ
Glia; 2004 Jan; 45(2):188-96. PubMed ID: 14730712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
